An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus

Journal of Clinical Investigation

Volumn 100, Issue 12, 1997, Pages 3019-3026

  James, Judith A ^a,b,e   Kaufman, Kenneth M ^a,b   Farris, A Darise ^b   Taylor Albert, Elizabeth ^a,b   Lehman, Thomas J A ^d   Harley, John B ^a,b,c,e  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d HOSPITAL FOR SPECIAL SURGERY   (United States)

^e UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

Autoantibodies; Autoimmune disease; Autoimmunity; SLE; Viral infection

Indexed keywords

ARTICLE; AUTOIMMUNE DISEASE; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; HUMAN; IMMUNOCHEMISTRY; IMMUNOGLOBULIN BLOOD LEVEL; PRIORITY JOURNAL; SEROCONVERSION; SYSTEMIC LUPUS ERYTHEMATOSUS; VIRUS DETECTION;

EID: 0031465706     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119856     Document Type: Article

References (36)

1. Tan, E.M., A.S. Cohen, J.F.Fries, A.T. Masi, D.J. McShane, N.F. Rothfield, J.G. Schaller, N. Talal, and R.J. Winchester. 1982. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25: 1271-1277.
2. James, J.A., T. Gross, R.H. Scofield, and J.B. Harley. 1995. PPPGMRPP immunization generates anti-Sm humoral autoimmunity and induces systemic lupus erythematosus in rabbits. J. Exp. Med. 181:453-461.
3. James, J.A., R.H. Scofield, and J.B. Harley. 1997. Lupus humoral autoimmunity after short peptide immunization. Ann. NY Acad. Sci. 815:124-127.
4. Evans, A.S., and J.C. Niederman. 1989. Epstein-Barr virus. In Viral Infections of Humans, Epidemiology and Control. A.S. Evans, editor. Plenum Publishing Corporation. New York. 265-292.
5. Evans, A.S., N.F. Rothfield, and N.F. Niederman. 1971. Raised antibody titers to E.B. virus in systemic lupus erythematosus. Lancet. i:167-168.
6. Klipple, J.H., J.L. Decker, P.M. Grimley, A.S. Evans, and N.F. Rothfield. 1973. Epstein-Barr virus antibody and lymphocyte tubuloreticular structures in systemic lupus erythematosus. Lancet. i:1057-1058.
7. Rothfield, N.F., A.S. Evans, and J.C. Niederman. 1973. Clinical and laboratory aspects of raised virus antibody titers in systemic lupus erythematosus. Ann. Rheum. Dis. 32:238-245.
8. Harley, J.B., A.S. Sestak, L.G. Willis, S.M. Fu, J.A. Hansen, and M. Reichlin. 1989. A model for disease heterogeneity in systemic lupus erythematosus. Relationships between histocompatibility antigens, autoantibodies and lymphopenia or renal disease. Arthritis Rheum. 32:413-419.
9. James, J.A., and J.B. Harley. 1996. Human lupus anti-spliceosome A protein autoantibodies bind contiguous surface structures and segregate into two sequential epitope binding patterns. J. Immunol. 156:4018-4026.
10. Stafford, H.A., C.J. Anderson, and M. Reichlin. 1995. Unmasking of anti-ribosomal P autoantibodies in healthy individuals. J. Immunol. 155:2754-2761.
11. Saito, I., B. Dervenius, T. Compton, and R.I. Fox. 1989. Detection of Epstein-Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjogren's syndrome. J. Exp. Med. 169:2191-2198.
12. Miyashita, E.M., B. Yang, K.M.C. Lam, D.H. Crawford, and D.A. Thorley-Lawson. 1995. A novel form of Epstein-Barr virus latency in normal B cells in vivo. Cell. 80:593-601.
13. Sanger, F. , S. Nicklen, and A.R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA. 74:5463-5467.
14. Lerner, M.R., N.C. Andrews, G. Miller, and J.A. Steitz. 1981. Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus. Proc. Natl. Acad. Sci. USA. 78:805-809.
15. Sculley, D.G., T.B. Sculley, and J.H. Pope. 1986. Reactions of sera from patients with rheumatoid arthritis, systemic lupus erythematosus and infectious mononucleosis to Epstein-Barr virus-induced polypeptides. J. Gen. Virol. 67: 2253-2258.
16. Kitagawa, H., S. Iho, Y. Takashi, and T. Hoshino. 1988. Detection of antibodies to the Epstein-Barr virus nuclear antigens in the sera from patients with systemic lupus erythematosus. Immunol. Lett. 17:249-252.
17. Yokochi, T., A. Yanagawa, Y. Kimura, and Y. Mizushima. 1989. High titer of antibody to the Epstein-Barr virus membrane antigen in sera from patients with rheumatoid arthritis and systemic lupus erythematosus. J. Rheumatol. 16:1029-1032.
18. Petersen, J., G. Rhodes, J. Roudier, and J.H. Vaughan. 1990. Altered immune response to glycine-rich sequences of Epstein-Barr nuclear antigen-1 in patients with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum. 33:993-1000.
19. Ngou, J., M. Segondy, J.-M. Seigneurin, and H. Graafland. 1990. Antibody responses against polypeptide components of Epstein-Barr virus-induced early diffuse antigen in patients with connective tissue disease. J. Med. Virol. 32: 39-46.
20. Ngou, J., H. Graafland, and M. Segondy. 1992. Antibodies against polypeptides of purified Epstein-Barr virus in sera from patients with connective tissue diseases. J. Autoimmun. 5:243-249.
21. James, J.A., and J.B. Harley. 1992. Linear epitopes mapping of an Sm B/B′ polypeptide. J. Immunol. 148:2074-2079.
22. James, J.A., M.J. Mamula, and J.B. Harley. 1994. Sequential autoantigenic determinants of the small nuclear ribonucleoprotein Sm D are shared by human lupus autoantibodies and MRL Ipr/lpr antibodies, Clin. Exp. Immunol. 98:419-426.
23. Sabbatini, A., S. Bombardieri, and P. Migliorini. 1993. Autoantibodies from patients with systemic lupus erythematosus bind a shared sequence of Sm D and Epstein-Barr virus-encoded nuclear antigen EBNA-1. Eur. J. Immunol. 23:1146-1152.
24. Marchini, B., M.P. Dolcher, A. Sabbatini, G. Klein, and P. Migliorini. 1994. Immune response to different sequences of the EBNA-1 molecule in Epstein-Barr virus-related disorders and in autoimmune diseases. J. Autoimmun. 7:179-191.
25. Rivkin, E., M. Vella, and R.G. Lahita. 1994. A heterogeneous immune response to an SmD-like epitope by SLE patients. J. Autoimmun. 7:119-132.
26. Vaughan, J.H., M.-D. Nguyen, J.R. Valbracht, K. Patrick, and G.H. Rhodes. 1995. Epstein-Barr virus-induced autoimmune responses. II. Immunoglobulin G autoantibodies to mimicking and nonmimicking epitopes. Presence in autoimmune disease. J. Clin. Invest. 95:1316-1327.
27. Tsokos, G.C., L.T. Magrath, and J.E. Balow. 1983. Epstein-Barr virus induces normal B cell responses but defective suppresser T cell responses in patients with systemic lupus erythematosus. J. Immunol. 131:1797-1801.
28. Levitskaya, J., M. Coram, V. Levitsky, S. Imreh, P.M. Steigerwald-Mullen, and M.G. Masucci. 1995. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature. 375:685-688.
29. Ying, L., R. de Waal Malefyt, F. Briere, C. Parhem, J.M. Bridon, J. Banchereau, K.W. Moore, and J. Xu. 1997. The EBV IL-10 homologue is a selective agonist with impaired binding to the IL-10 receptor. J. Immunol. 158: 604-613.
30. Taga, K., J. Chretien, B. Cherney, L. Diaz. M. Brown, and G. Tosada. 1994. Interleukin-10 inhibits apoptotic cell death in infectious mononucleosis t cells. J. Clin. Invest. 94:251-260.
31. de Waal Malefyt, R., J. Haanen, H. Spits, M.-G. Roncarlo, A. te Velde, C. Figdor, K. Johnson, R. Kastelein, H. Yssl, and J.E. de Vreis. 1991. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via down regulation of class II major histocompatibility complex expression. J. Exp. Med. 178:439-447.
32. Miyazaki, I., R.K. Cheung, and H.M. Dosch. 1993. Viral interleukin 10 is critical for the induction of B cell growth transformation by Epstein-Barr virus. J. Exp. Med. 178:439-447.
33. Gregory, C.D., C. Dive, S. Henderson, C.A. Smith, G.T. Williams, J. Gordon, and A.B. Rickinson. 1991. Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Nature. 349:612-614.
34. Henderson, S., D. Huen, M. Rowe, C. Dawson, G. Johnson, and A. Rickinson. 1993. Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. Proc. Natl. Acad. Sci. USA. 90:8479-8483.
35. Strasser, A., S. Whittingham, D.L. Vaux, M.L. Bath, J.M. Adams. S. Cory, and A.W. Harris. 1991. Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc. Natl. Acad. Sci. USA. 88:8661-8665.
36. Vaughan, J.H. 1995. The Epstein-Barr virus in autoimmunity. Springer Semin. Immunopathol. 17:203-230.